Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO5241 | Myristica fragrans | Species | Myristicaceae | Eukaryota | TM-MC* | |||
NPO21771 | Citrus trifoliata | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | TM-MC* | |||
NPO20553 | Zingiber officinale | Species | Zingiberaceae | Eukaryota | TM-MC* | |||
NPO5986 | Ziziphus jujuba | Species | Rhamnaceae | Eukaryota | TM-MC* | |||
NPO26657 | Conocephalum conicum | Species | Conocephalaceae | Eukaryota | TCMID* | |||
NPO32949 | diphlolophium buchanani | Species | NA | NA | J. Nat. Prod.,1995,58: 128-130 | |||
NPO10515 | Angelicae sinensis radix | NA | NA | NA | TCMSP* | |||
NPO2921 | Angelica acutiloba | Species | Apiaceae | Eukaryota | TM-MC* | |||
NPO11438 | Angelica gigas | Species | Apiaceae | Eukaryota | TM-MC* | |||
NPO15462 | Angelica sinensis | Species | Apiaceae | Eukaryota | TM-MC* | |||
NPO9546 | Cinamomum cassia | NA | NA | NA | TM-MC* | |||
NPO8255 | Cinnamomum aromaticum | Species | Lauraceae | Eukaryota | TM-MC* | |||
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO5270 | Citrus natsudaidai | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO3987 | Syzygium aromaticum | Species | Myrtaceae | Eukaryota | TM-MC* | |||
NPO23628 | Imperata cylindrica | Species | Poaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT299 | Individual Protein | Androgen Receptor | Rattus norvegicus | IC50 | = | 204173.79 | nM | 16134935 |
NPT2 | Others | Unspecified | Ki | = | 14200 | nM | 18505250 | |
NPT3540 | Organism | Cochliobolus lunatus | Cochliobolus lunatus | Activity | = | 0.29 | millimeter/hr | 18505250 |
NPT3540 | Organism | Cochliobolus lunatus | Cochliobolus lunatus | Activity | = | 56 | hr | 18505250 |
NPT3540 | Organism | Cochliobolus lunatus | Cochliobolus lunatus | Activity | = | 0 | millimeter/hr | 18505250 |
NPT3540 | Organism | Cochliobolus lunatus | Cochliobolus lunatus | Activity | > | 1800 | hr | 18505250 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | MIC | = | 400 | ug/ml | 8463795 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 400 | ug/ml | 8463795 |
NPT523 | Organism | Malassezia furfur | Malassezia furfur | MIC | = | 200 | ug/ml | 8463795 |
NPT1819 | Organism | Microsporum canis | Arthroderma otae | MIC | > | 50 | ug/ml | 10543891 |
NPT327 | Organism | Microsporum gypseum | Microsporum gypseum | MIC | > | 50 | ug/ml | 10543891 |
NPT330 | Organism | Trichophyton mentagrophytes | Trichophyton mentagrophytes | MIC | > | 50 | ug/ml | 10543891 |
NPT329 | Organism | Trichophyton rubrum | Trichophyton rubrum | MIC | > | 50 | ug/ml | 10543891 |
NPT328 | Organism | Epidermophyton floccosum | Epidermophyton floccosum | MIC | > | 50 | ug/ml | 10543891 |
NPT2 | Others | Unspecified | Inhibition | = | 28 | % | 21843909 | |
NPT2 | Others | Unspecified | Inhibition | = | 42 | % | 21843909 | |
NPT2 | Others | Unspecified | Inhibition | = | 90 | % | 21843909 | |
NPT2 | Others | Unspecified | Inhibition | = | 96 | % | 21843909 | |
NPT2 | Others | Unspecified | Inhibition | = | 91 | % | 21843909 | |
NPT2 | Others | Unspecified | Inhibition | = | 82 | % | 21843909 | |
NPT1 | Others | Radical scavenging activity | IC50 | = | 40670 | nM | 21843909 | |
NPT2 | Others | Unspecified | IC50 | = | 8840 | nM | 21843909 | |
NPT2 | Others | Unspecified | IC50 | = | 42260 | nM | 21843909 | |
NPT2 | Others | Unspecified | Activity | = | 0.32 | 21843909 | ||
NPT2 | Others | Unspecified | Activity | = | 0.37 | 21843909 | ||
NPT2 | Others | Unspecified | Activity | = | 0.41 | 21843909 | ||
NPT2 | Others | Unspecified | Activity | = | 0.43 | 21843909 | ||
NPT554 | Organism | Candida glabrata | Candida glabrata | IC50 | = | 71.61 | ug/ml | 25686593 |
NPT20 | Organism | Candida albicans | Candida albicans | MFC | = | 1000 | ug/ml | 25686593 |
NPT20 | Organism | Candida albicans | Candida albicans | IC50 | = | 82.98 | ug/ml | 25686593 |
NPT554 | Organism | Candida glabrata | Candida glabrata | MFC | = | 500 | ug/ml | 25686593 |
NPT186 | Organism | Candida tropicalis | Candida tropicalis | IC50 | = | 127.73 | ug/ml | 25686593 |
NPT186 | Organism | Candida tropicalis | Candida tropicalis | MFC | = | 1000 | ug/ml | 25686593 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC233731 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC246358 |
1.0 | High Similarity | NPC36108 |
1.0 | High Similarity | NPC7097 |
0.9806 | High Similarity | NPC78918 |
0.9806 | High Similarity | NPC257124 |
0.9806 | High Similarity | NPC139617 |
0.9806 | High Similarity | NPC8547 |
0.9806 | High Similarity | NPC173746 |
0.9806 | High Similarity | NPC156840 |
0.9429 | High Similarity | NPC195873 |
0.9417 | High Similarity | NPC227894 |
0.9352 | High Similarity | NPC221049 |
0.9307 | High Similarity | NPC310905 |
0.9307 | High Similarity | NPC12714 |
0.9266 | High Similarity | NPC164386 |
0.9266 | High Similarity | NPC293619 |
0.9266 | High Similarity | NPC39793 |
0.9266 | High Similarity | NPC259638 |
0.9182 | High Similarity | NPC107588 |
0.9182 | High Similarity | NPC70744 |
0.9182 | High Similarity | NPC137537 |
0.9182 | High Similarity | NPC255675 |
0.9182 | High Similarity | NPC470626 |
0.9182 | High Similarity | NPC164706 |
0.9182 | High Similarity | NPC272471 |
0.9174 | High Similarity | NPC193067 |
0.9151 | High Similarity | NPC137685 |
0.9126 | High Similarity | NPC292792 |
0.9099 | High Similarity | NPC311595 |
0.9099 | High Similarity | NPC281298 |
0.9099 | High Similarity | NPC181969 |
0.9099 | High Similarity | NPC320987 |
0.9099 | High Similarity | NPC310338 |
0.9099 | High Similarity | NPC24474 |
0.9099 | High Similarity | NPC299406 |
0.9099 | High Similarity | NPC20674 |
0.9065 | High Similarity | NPC55300 |
0.9018 | High Similarity | NPC117780 |
0.9018 | High Similarity | NPC10932 |
0.9018 | High Similarity | NPC148615 |
0.9018 | High Similarity | NPC242885 |
0.9018 | High Similarity | NPC247364 |
0.9018 | High Similarity | NPC35071 |
0.9018 | High Similarity | NPC232084 |
0.9018 | High Similarity | NPC61516 |
0.9018 | High Similarity | NPC2058 |
0.9018 | High Similarity | NPC227217 |
0.9018 | High Similarity | NPC95614 |
0.9018 | High Similarity | NPC165133 |
0.9018 | High Similarity | NPC177475 |
0.9018 | High Similarity | NPC56214 |
0.9018 | High Similarity | NPC232316 |
0.9018 | High Similarity | NPC229401 |
0.9018 | High Similarity | NPC202474 |
0.8981 | High Similarity | NPC165646 |
0.8942 | High Similarity | NPC12987 |
0.8942 | High Similarity | NPC474603 |
0.8938 | High Similarity | NPC207613 |
0.8938 | High Similarity | NPC158949 |
0.8938 | High Similarity | NPC109083 |
0.8938 | High Similarity | NPC14007 |
0.8938 | High Similarity | NPC189844 |
0.8938 | High Similarity | NPC60962 |
0.8938 | High Similarity | NPC269843 |
0.8938 | High Similarity | NPC224814 |
0.8938 | High Similarity | NPC204466 |
0.8919 | High Similarity | NPC86947 |
0.8868 | High Similarity | NPC258171 |
0.886 | High Similarity | NPC312675 |
0.886 | High Similarity | NPC113865 |
0.886 | High Similarity | NPC70752 |
0.886 | High Similarity | NPC470212 |
0.886 | High Similarity | NPC473853 |
0.886 | High Similarity | NPC184651 |
0.886 | High Similarity | NPC160380 |
0.886 | High Similarity | NPC194416 |
0.886 | High Similarity | NPC343720 |
0.886 | High Similarity | NPC476343 |
0.886 | High Similarity | NPC201777 |
0.886 | High Similarity | NPC54872 |
0.886 | High Similarity | NPC262156 |
0.886 | High Similarity | NPC470804 |
0.886 | High Similarity | NPC177291 |
0.886 | High Similarity | NPC324571 |
0.886 | High Similarity | NPC38996 |
0.8839 | High Similarity | NPC212743 |
0.8818 | High Similarity | NPC294941 |
0.8812 | High Similarity | NPC107522 |
0.8783 | High Similarity | NPC85488 |
0.8783 | High Similarity | NPC286573 |
0.8783 | High Similarity | NPC262253 |
0.8783 | High Similarity | NPC473411 |
0.8783 | High Similarity | NPC114298 |
0.8783 | High Similarity | NPC71579 |
0.8783 | High Similarity | NPC209567 |
0.8783 | High Similarity | NPC41562 |
0.8761 | High Similarity | NPC226629 |
0.8761 | High Similarity | NPC135961 |
0.8738 | High Similarity | NPC131587 |
0.8713 | High Similarity | NPC114325 |
0.8707 | High Similarity | NPC317769 |
0.8707 | High Similarity | NPC280704 |
0.8707 | High Similarity | NPC140359 |
0.8707 | High Similarity | NPC257976 |
0.8707 | High Similarity | NPC31344 |
0.8707 | High Similarity | NPC160900 |
0.8707 | High Similarity | NPC163083 |
0.8707 | High Similarity | NPC228922 |
0.8707 | High Similarity | NPC106659 |
0.8707 | High Similarity | NPC18984 |
0.8707 | High Similarity | NPC242372 |
0.8707 | High Similarity | NPC471693 |
0.8707 | High Similarity | NPC164778 |
0.8707 | High Similarity | NPC4181 |
0.8707 | High Similarity | NPC229084 |
0.8707 | High Similarity | NPC197757 |
0.8707 | High Similarity | NPC238810 |
0.8707 | High Similarity | NPC13020 |
0.8704 | High Similarity | NPC127326 |
0.8696 | High Similarity | NPC290451 |
0.8696 | High Similarity | NPC49341 |
0.8696 | High Similarity | NPC127389 |
0.8684 | High Similarity | NPC474565 |
0.8641 | High Similarity | NPC109955 |
0.8632 | High Similarity | NPC312404 |
0.8632 | High Similarity | NPC5796 |
0.8632 | High Similarity | NPC20443 |
0.8632 | High Similarity | NPC74478 |
0.8632 | High Similarity | NPC246704 |
0.8632 | High Similarity | NPC60517 |
0.8632 | High Similarity | NPC183446 |
0.8632 | High Similarity | NPC206487 |
0.8632 | High Similarity | NPC146886 |
0.8632 | High Similarity | NPC273686 |
0.8624 | High Similarity | NPC179309 |
0.8611 | High Similarity | NPC75440 |
0.8609 | High Similarity | NPC166759 |
0.8584 | High Similarity | NPC280001 |
0.8571 | High Similarity | NPC110764 |
0.8559 | High Similarity | NPC289459 |
0.8559 | High Similarity | NPC194519 |
0.8559 | High Similarity | NPC57490 |
0.8559 | High Similarity | NPC82483 |
0.8559 | High Similarity | NPC233410 |
0.8559 | High Similarity | NPC280767 |
0.8559 | High Similarity | NPC257589 |
0.8559 | High Similarity | NPC300326 |
0.8559 | High Similarity | NPC29008 |
0.8559 | High Similarity | NPC271985 |
0.8559 | High Similarity | NPC203133 |
0.8559 | High Similarity | NPC9067 |
0.8559 | High Similarity | NPC472093 |
0.8559 | High Similarity | NPC116907 |
0.8559 | High Similarity | NPC60885 |
0.8559 | High Similarity | NPC298757 |
0.8559 | High Similarity | NPC53305 |
0.8559 | High Similarity | NPC148627 |
0.8559 | High Similarity | NPC117214 |
0.8559 | High Similarity | NPC265483 |
0.8559 | High Similarity | NPC193544 |
0.8559 | High Similarity | NPC475169 |
0.8559 | High Similarity | NPC266705 |
0.8559 | High Similarity | NPC299584 |
0.8559 | High Similarity | NPC228771 |
0.8559 | High Similarity | NPC208950 |
0.8559 | High Similarity | NPC234400 |
0.8559 | High Similarity | NPC221077 |
0.8559 | High Similarity | NPC58279 |
0.8559 | High Similarity | NPC17943 |
0.8559 | High Similarity | NPC251855 |
0.8547 | High Similarity | NPC165375 |
0.8547 | High Similarity | NPC220598 |
0.8545 | High Similarity | NPC203924 |
0.8545 | High Similarity | NPC226250 |
0.8545 | High Similarity | NPC245552 |
0.8534 | High Similarity | NPC145780 |
0.8534 | High Similarity | NPC285289 |
0.8532 | High Similarity | NPC165386 |
0.8509 | High Similarity | NPC474214 |
0.8509 | High Similarity | NPC474040 |
0.8509 | High Similarity | NPC205502 |
0.8509 | High Similarity | NPC124916 |
0.8491 | Intermediate Similarity | NPC196479 |
0.8487 | Intermediate Similarity | NPC92207 |
0.8487 | Intermediate Similarity | NPC127937 |
0.8487 | Intermediate Similarity | NPC191037 |
0.8487 | Intermediate Similarity | NPC18924 |
0.8487 | Intermediate Similarity | NPC304630 |
0.8487 | Intermediate Similarity | NPC120225 |
0.8487 | Intermediate Similarity | NPC90128 |
0.8487 | Intermediate Similarity | NPC303680 |
0.8487 | Intermediate Similarity | NPC179777 |
0.8487 | Intermediate Similarity | NPC84076 |
0.8487 | Intermediate Similarity | NPC276014 |
0.8487 | Intermediate Similarity | NPC78974 |
0.8487 | Intermediate Similarity | NPC274356 |
0.8487 | Intermediate Similarity | NPC223136 |
0.8487 | Intermediate Similarity | NPC178284 |
0.8487 | Intermediate Similarity | NPC103823 |
0.8487 | Intermediate Similarity | NPC214406 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC233731 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9806 | High Similarity | NPD228 | Approved |
0.8713 | High Similarity | NPD9296 | Approved |
0.8707 | High Similarity | NPD4379 | Clinical (unspecified phase) |
0.8596 | High Similarity | NPD1357 | Approved |
0.8417 | Intermediate Similarity | NPD9494 | Approved |
0.8393 | Intermediate Similarity | NPD5283 | Phase 1 |
0.8279 | Intermediate Similarity | NPD3027 | Phase 3 |
0.8211 | Intermediate Similarity | NPD3145 | Approved |
0.8211 | Intermediate Similarity | NPD3144 | Approved |
0.8145 | Intermediate Similarity | NPD2674 | Phase 3 |
0.8108 | Intermediate Similarity | NPD2684 | Approved |
0.8103 | Intermediate Similarity | NPD5536 | Phase 2 |
0.8036 | Intermediate Similarity | NPD3022 | Approved |
0.8036 | Intermediate Similarity | NPD3021 | Approved |
0.8018 | Intermediate Similarity | NPD290 | Approved |
0.7937 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7937 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7937 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7903 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.789 | Intermediate Similarity | NPD291 | Approved |
0.7826 | Intermediate Similarity | NPD7843 | Approved |
0.7823 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7822 | Intermediate Similarity | NPD111 | Approved |
0.7795 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7795 | Intermediate Similarity | NPD1613 | Approved |
0.7787 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7787 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7778 | Intermediate Similarity | NPD7157 | Approved |
0.7768 | Intermediate Similarity | NPD968 | Approved |
0.7705 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7699 | Intermediate Similarity | NPD1358 | Approved |
0.7692 | Intermediate Similarity | NPD9295 | Approved |
0.7672 | Intermediate Similarity | NPD9377 | Approved |
0.7672 | Intermediate Similarity | NPD9379 | Approved |
0.7627 | Intermediate Similarity | NPD6671 | Approved |
0.7623 | Intermediate Similarity | NPD3705 | Approved |
0.7547 | Intermediate Similarity | NPD9365 | Approved |
0.754 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7521 | Intermediate Similarity | NPD821 | Approved |
0.75 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2934 | Approved |
0.75 | Intermediate Similarity | NPD9280 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2933 | Approved |
0.75 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.7477 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7459 | Intermediate Similarity | NPD4626 | Approved |
0.7456 | Intermediate Similarity | NPD3134 | Approved |
0.7442 | Intermediate Similarity | NPD1726 | Clinical (unspecified phase) |
0.7431 | Intermediate Similarity | NPD2859 | Approved |
0.7431 | Intermediate Similarity | NPD844 | Approved |
0.7431 | Intermediate Similarity | NPD2860 | Approved |
0.7395 | Intermediate Similarity | NPD9299 | Approved |
0.7387 | Intermediate Similarity | NPD3020 | Approved |
0.7385 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7364 | Intermediate Similarity | NPD288 | Approved |
0.7344 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD3060 | Approved |
0.7323 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7321 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7317 | Intermediate Similarity | NPD9381 | Approved |
0.7317 | Intermediate Similarity | NPD9384 | Approved |
0.7302 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7295 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7265 | Intermediate Similarity | NPD5451 | Approved |
0.7265 | Intermediate Similarity | NPD556 | Approved |
0.7239 | Intermediate Similarity | NPD2161 | Phase 2 |
0.7231 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7231 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7231 | Intermediate Similarity | NPD5109 | Approved |
0.7231 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7222 | Intermediate Similarity | NPD9622 | Approved |
0.72 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7197 | Intermediate Similarity | NPD447 | Suspended |
0.719 | Intermediate Similarity | NPD709 | Approved |
0.7177 | Intermediate Similarity | NPD2668 | Approved |
0.7177 | Intermediate Similarity | NPD1778 | Approved |
0.7177 | Intermediate Similarity | NPD2667 | Approved |
0.7177 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7177 | Intermediate Similarity | NPD5846 | Approved |
0.7176 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7165 | Intermediate Similarity | NPD1283 | Approved |
0.7154 | Intermediate Similarity | NPD2669 | Clinical (unspecified phase) |
0.7154 | Intermediate Similarity | NPD1182 | Approved |
0.7154 | Intermediate Similarity | NPD7095 | Approved |
0.7143 | Intermediate Similarity | NPD2232 | Approved |
0.7143 | Intermediate Similarity | NPD2230 | Approved |
0.7143 | Intermediate Similarity | NPD2233 | Approved |
0.7132 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7132 | Intermediate Similarity | NPD7153 | Discontinued |
0.712 | Intermediate Similarity | NPD3496 | Discontinued |
0.7113 | Intermediate Similarity | NPD824 | Approved |
0.7109 | Intermediate Similarity | NPD987 | Approved |
0.7105 | Intermediate Similarity | NPD940 | Approved |
0.7105 | Intermediate Similarity | NPD846 | Approved |
0.7101 | Intermediate Similarity | NPD5241 | Discontinued |
0.7097 | Intermediate Similarity | NPD5691 | Approved |
0.7097 | Intermediate Similarity | NPD1651 | Approved |
0.7087 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7087 | Intermediate Similarity | NPD1669 | Approved |
0.7087 | Intermediate Similarity | NPD6582 | Phase 2 |
0.708 | Intermediate Similarity | NPD4237 | Approved |
0.708 | Intermediate Similarity | NPD4236 | Phase 3 |
0.708 | Intermediate Similarity | NPD4162 | Approved |
0.7071 | Intermediate Similarity | NPD1754 | Clinical (unspecified phase) |
0.7068 | Intermediate Similarity | NPD230 | Phase 1 |
0.7063 | Intermediate Similarity | NPD776 | Approved |
0.7063 | Intermediate Similarity | NPD1091 | Approved |
0.7063 | Intermediate Similarity | NPD422 | Phase 1 |
0.7059 | Intermediate Similarity | NPD1375 | Discontinued |
0.7054 | Intermediate Similarity | NPD4624 | Approved |
0.7054 | Intermediate Similarity | NPD9620 | Approved |
0.7054 | Intermediate Similarity | NPD9619 | Approved |
0.7054 | Intermediate Similarity | NPD9621 | Approved |
0.7042 | Intermediate Similarity | NPD1653 | Approved |
0.7031 | Intermediate Similarity | NPD9634 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7029 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD6331 | Phase 2 |
0.7025 | Intermediate Similarity | NPD1241 | Discontinued |
0.7008 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7008 | Intermediate Similarity | NPD2337 | Clinical (unspecified phase) |
0.7008 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7 | Intermediate Similarity | NPD4357 | Discontinued |
0.7 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.6984 | Remote Similarity | NPD3847 | Discontinued |
0.6978 | Remote Similarity | NPD2219 | Phase 1 |
0.6977 | Remote Similarity | NPD3053 | Approved |
0.6977 | Remote Similarity | NPD1817 | Approved |
0.6977 | Remote Similarity | NPD1819 | Approved |
0.6977 | Remote Similarity | NPD1820 | Approved |
0.6977 | Remote Similarity | NPD3055 | Approved |
0.6977 | Remote Similarity | NPD1818 | Approved |
0.6966 | Remote Similarity | NPD1934 | Approved |
0.6964 | Remote Similarity | NPD1809 | Phase 2 |
0.6963 | Remote Similarity | NPD6896 | Approved |
0.6963 | Remote Similarity | NPD6895 | Approved |
0.6957 | Remote Similarity | NPD5177 | Phase 3 |
0.6953 | Remote Similarity | NPD3676 | Clinical (unspecified phase) |
0.6953 | Remote Similarity | NPD4749 | Approved |
0.695 | Remote Similarity | NPD4123 | Phase 3 |
0.6947 | Remote Similarity | NPD4908 | Phase 1 |
0.6944 | Remote Similarity | NPD9094 | Approved |
0.6942 | Remote Similarity | NPD5535 | Approved |
0.694 | Remote Similarity | NPD5735 | Approved |
0.694 | Remote Similarity | NPD3657 | Discovery |
0.6937 | Remote Similarity | NPD845 | Approved |
0.6934 | Remote Similarity | NPD7266 | Discontinued |
0.6934 | Remote Similarity | NPD3540 | Phase 1 |
0.6929 | Remote Similarity | NPD1535 | Discovery |
0.6929 | Remote Similarity | NPD1281 | Approved |
0.6923 | Remote Similarity | NPD258 | Approved |
0.6923 | Remote Similarity | NPD257 | Approved |
0.6918 | Remote Similarity | NPD2801 | Approved |
0.6918 | Remote Similarity | NPD2977 | Approved |
0.6918 | Remote Similarity | NPD2978 | Approved |
0.6917 | Remote Similarity | NPD259 | Phase 1 |
0.6912 | Remote Similarity | NPD6029 | Clinical (unspecified phase) |
0.6912 | Remote Similarity | NPD6028 | Clinical (unspecified phase) |
0.6899 | Remote Similarity | NPD5310 | Approved |
0.6899 | Remote Similarity | NPD5311 | Approved |
0.6899 | Remote Similarity | NPD8651 | Approved |
0.6897 | Remote Similarity | NPD9500 | Approved |
0.6889 | Remote Similarity | NPD6653 | Approved |
0.6889 | Remote Similarity | NPD2492 | Phase 1 |
0.6889 | Remote Similarity | NPD2653 | Approved |
0.688 | Remote Similarity | NPD1894 | Discontinued |
0.688 | Remote Similarity | NPD9545 | Approved |
0.6879 | Remote Similarity | NPD1511 | Approved |
0.6875 | Remote Similarity | NPD1481 | Phase 2 |
0.6875 | Remote Similarity | NPD1840 | Phase 2 |
0.6875 | Remote Similarity | NPD1608 | Approved |
0.6875 | Remote Similarity | NPD3111 | Phase 1 |
0.6866 | Remote Similarity | NPD5837 | Clinical (unspecified phase) |
0.6866 | Remote Similarity | NPD825 | Approved |
0.6866 | Remote Similarity | NPD826 | Approved |
0.6864 | Remote Similarity | NPD1444 | Approved |
0.6864 | Remote Similarity | NPD1445 | Approved |
0.6861 | Remote Similarity | NPD3539 | Phase 1 |
0.6842 | Remote Similarity | NPD597 | Approved |
0.6842 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD601 | Approved |
0.6842 | Remote Similarity | NPD6798 | Discontinued |
0.6842 | Remote Similarity | NPD598 | Approved |
0.6838 | Remote Similarity | NPD6111 | Discontinued |
0.6838 | Remote Similarity | NPD9610 | Approved |
0.6838 | Remote Similarity | NPD9608 | Approved |
0.6838 | Remote Similarity | NPD9501 | Approved |
0.6831 | Remote Similarity | NPD4739 | Approved |
0.6825 | Remote Similarity | NPD5585 | Approved |
0.6824 | Remote Similarity | NPD3882 | Suspended |
0.6822 | Remote Similarity | NPD5327 | Phase 3 |
0.6822 | Remote Similarity | NPD3685 | Discontinued |
0.6818 | Remote Similarity | NPD600 | Approved |
0.6818 | Remote Similarity | NPD596 | Approved |
0.6815 | Remote Similarity | NPD6355 | Discontinued |
0.6815 | Remote Similarity | NPD555 | Phase 2 |
0.6812 | Remote Similarity | NPD2029 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD9552 | Approved |
0.6806 | Remote Similarity | NPD3686 | Approved |
0.6806 | Remote Similarity | NPD3687 | Approved |
PubChem CID   | 1549041 |
ChEMBL   | CHEMBL445206 |
ZINC   |
Molecular Weight:   | 164.08 |
ALogP:   | 0.3952 |
MLogP:   | 2.34 |
XLogP:   | 2.805 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 29.46 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 1 |
# Rings:   | 1 |
# Heavy Atoms:   | 12 |